Sphingolipids and impaired hypoxic stress responses in Huntington disease. (April 2023)

• Record Type: Journal Article
• Authors: Burtscher, Johannes; Pepe, Giuseppe; Maharjan, Niran; Riguet, Nathan; Di Pardo, Alba; Maglione, Vittorio; Millet, Grégoire P.
• Is Part Of: Progress in lipid research. Volume 90(2023)
• Publication Date: 2023-04
• Subjects: Sphingolipids -- Huntington disease -- hypoxia -- conditioning -- mitochondria; Lipids -- Periodicals; Lipids -- Periodicals; Lipides -- Périodiques; Lipiden; 572.57
• DOI: 10.1016/j.plipres.2023.101224
• Languages: English
• ISSNs: 0163-7827

Abstract

Abstract: Huntington disease (HD) is a debilitating, currently incurable disease. Protein aggregation and metabolic deficits are pathological hallmarks but their link to neurodegeneration and symptoms remains debated. Here, we summarize alterations in the levels of different sphingolipids in an attempt to characterize sphingolipid patterns specific to HD, an additional molecular hallmark of the disease. Based on the crucial role of sphingolipids in maintaining cellular homeostasis, the dynamic regulation of sphingolipids upon insults and their involvement in cellular stress responses, we hypothesize that maladaptations or blunted adaptations, especially following cellular stress due to reduced oxygen supply (hypoxia) contribute to the development of pathology in HD. We review how sphingolipids shape cellular energy metabolism and control proteostasis and suggest how these functions may fail in HD and in combination with additional insults. Finally, we evaluate the potential of improving cellular resilience in HD by conditioning approaches (improving the efficiency of cellular stress responses) and the role of sphingolipids therein. Sphingolipid metabolism is crucial for cellular homeostasis and for adaptations following cellular stress, including hypoxia. Inadequate cellular management of hypoxic stress likely contributes to HD progression, and sphingolipids are potential mediators. Targeting sphingolipids and the hypoxic stress response are novel treatment strategies for HD.